- Home
- FINW vs VIGL Comparison
FINW vs VIGL Comparison
Compare FINW & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINW
- VIGL
- Stock Information
- Founded
- FINW 1999
- VIGL 2020
- Country
- FINW United States
- VIGL United States
- Employees
- FINW N/A
- VIGL N/A
- Industry
- FINW Commercial Banks
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- FINW Finance
- VIGL Health Care
- Exchange
- FINW Nasdaq
- VIGL Nasdaq
- Market Cap
- FINW 207.1M
- VIGL 134.9M
- IPO Year
- FINW 2021
- VIGL 2022
- Fundamental
- Price
- FINW $15.57
- VIGL $8.05
- Analyst Decision
- FINW Buy
- VIGL Buy
- Analyst Count
- FINW 4
- VIGL 7
- Target Price
- FINW $20.75
- VIGL $8.00
- AVG Volume (30 Days)
- FINW 77.1K
- VIGL 1.1M
- Earning Date
- FINW 07-24-2025
- VIGL 08-12-2025
- Dividend Yield
- FINW N/A
- VIGL N/A
- EPS Growth
- FINW N/A
- VIGL N/A
- EPS
- FINW 0.91
- VIGL N/A
- Revenue
- FINW $72,056,000.00
- VIGL N/A
- Revenue This Year
- FINW $37.77
- VIGL N/A
- Revenue Next Year
- FINW $23.58
- VIGL N/A
- P/E Ratio
- FINW $16.86
- VIGL N/A
- Revenue Growth
- FINW 7.66
- VIGL N/A
- 52 Week Low
- FINW $10.52
- VIGL $1.31
- 52 Week High
- FINW $20.94
- VIGL $8.06
- Technical
- Relative Strength Index (RSI)
- FINW 60.72
- VIGL 88.18
- Support Level
- FINW $15.23
- VIGL $7.86
- Resistance Level
- FINW $16.23
- VIGL $8.05
- Average True Range (ATR)
- FINW 0.54
- VIGL 0.02
- MACD
- FINW 0.14
- VIGL -0.15
- Stochastic Oscillator
- FINW 72.73
- VIGL 73.15
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.